" class="no-js "lang="en-US"> Hilary Latham - Medtech Alert
Wednesday, March 22, 2023
Hilary Latham

Hilary Latham

About Hilary Latham

Hilary Latham is the Marketing Director for Bio-Rad Life Sciences Group Antibody Division. Bio-Rad is one of the top five life science companies in the world providing instruments, software, consumables, reagents for cell biology, gene expression, protein purification, protein quantitation, drug discovery and manufacture, food safety, and science education.

Having completed a degree in biochemistry from the University of Birmingham, Hilary has worked for some of the key global life science companies including Amersham Life Sciences (now GE Healthcare), The Automation Partnership (Sartorius Stedim), Genetix (Danaher Corporation) and Promega Corporation. Her roles have spanned life science reagent sales, product management, marketing communications and marketing management across many varied areas of the life sciences. She has also worked in one of the top London Public Relations firms.

She currently manages a team of Product Managers, E Business and Marketing Communication Managers and Specialists and New Product and Application Scientists.

She is particularly interested in marketing and communication strategies.


Complex task management such as the design and execution of creative, multi -channel tactical marketing plans, initiatives, sales campaigns and training.
Production of innovative promotional material such as sales tools, web and e communications, advertising concepts and PR
Product management – including introducing new products into global /regional markets combined with expertise in product life cycle management from inception through product development, new product introduction and market development (~£1M platforms to £ K-Ms consumables)
Clear and effective communication from presentations to written content
Up-to-date market knowledge and technical competence
Experienced in Strategic Selling, Face to Face Selling and SPIN selling concepts

Specialties: Life science marketing communications practice offering marketing initiatives across advertising, PR, media, sales tools and collateral, writing, digital design and branding and to providing expert counsel in relation to client marketing plans

Related Story

Bio-Rad Introduces Anti-Evolocumab Antibodies for Use in Preclinical and Clinical Drug Development

August 26 2022

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and […]